The changing and dynamic epidemiology of meningococcal disease.
about
Meningococcal VaccinationsMeningococcal disease in childhood: epidemiology, clinical features and preventionEpidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriageSerogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015Review of meningococcal vaccines with updates on immunization in adultsMulticomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United StatesCharacteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Meningococcal B vaccination: real-world experience and future perspectives.Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin.Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort studyImplications of differential age distribution of disease-associated meningococcal lineages for vaccine development.An epidemiological review of changes in meningococcal biology during the last 100 yearsMeningococcal disease outbreak related to the World Scout Jamboree in Japan, 2015.A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine.Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia.The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.Geotemporal analysis of Neisseria meningitidis clones in the United States: 2000-2005.Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease-A Meta-AnalysisInvestigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR.Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec).Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvantCost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.The usefulness of school-based syndromic surveillance for detecting malaria epidemics: experiences from a pilot project in EthiopiaImpact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, BrazilGenomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidisGenomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.Health and safety issues for travelers attending the World Cup and Summer Olympic and Paralympic Games in Brazil, 2014 to 2016.[Meningococcus B: control of two outbreaks by vaccination]The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.
P2860
Q26752993-1B27699B-D42D-4379-BA2D-F0E98C68C592Q26770704-FD30F684-ED2B-499D-8106-7A92C36AA10FQ26770707-600C48BD-39B6-47DD-90C0-A00DC851816DQ28554935-F66EB99B-4AE9-40E4-B01C-6425EF80AEF7Q28828692-B91E54D7-10B7-4EDD-8370-7EE5BD076678Q30235072-E19ABB9A-9CF3-43D8-AAB3-5405C58F9902Q30248749-F57C99C2-F9F5-4AB8-91FF-055CE43EF8B3Q30249575-1B466CDA-58C0-4DD3-B548-EB01106B9FC9Q30653243-CDCA1721-B6DA-4F92-A037-E1E2ED0F9E06Q31029757-FFBE2BD3-5A94-4588-9309-C2F3BE95AABFQ33703560-98712982-AD2F-4180-97D6-587D4901B88EQ33703622-C2180755-0EA2-40B7-9B20-396698CBB7B8Q33743483-ECA3372A-B27D-4FE1-8213-DE2D9282A3D3Q33850814-AE80B52C-A9FD-4A30-A69E-5E0565FDA949Q33917031-6AE51039-9A4D-492D-995E-8B0754F6922DQ33939014-AD2DFC5C-A406-42F2-BBA1-9DECD399F8D6Q34290891-D924C521-B28C-485C-80FE-8B024A4A19FDQ34291176-1E807AE3-C0A2-4946-BEC1-C7F6ECB03559Q34316082-1E1EA008-0431-4BA1-B4A9-482B92773529Q34481220-9066BA6F-C868-421D-90FE-1C56B74EE3E2Q34500581-7CFACF78-6A08-4188-AC91-C8CA8B5BE410Q34785389-7A5CC843-2CC7-473B-B35D-DE39F0886F8BQ35069945-7A9E2B1E-87E4-49DB-BCA6-41A861005B2FQ35108361-EF574AD5-9A02-4801-9DBB-FC1D069A095AQ35656530-592738DE-4FE0-4F10-8DD1-D50DFE0383A7Q35712025-B635C395-0544-4CD1-8727-68B14BC9C607Q35799561-8E291FE0-E36F-4FCF-8CA4-E51DFAF848F2Q35865540-39608EB7-C4BE-47F6-A77E-D72FC590AC7CQ35867241-1064B3C3-CFA4-4632-8BA9-0DA2E3219651Q35887397-1C7C02BA-645C-4FA7-9C97-B05F08A1BEFAQ35887617-22A6AE5B-C73E-4BD4-98EE-E7BE4CADA4ABQ35889640-F1BBFD59-545B-4E5E-A38B-B7FAE9A643B6Q35922195-9CFE9D89-744D-47CC-8A24-D9360F5F5F20Q36197611-A4AA9C26-008D-4B24-811B-A9358B9C8A86Q36253028-1C3F88DF-F2C1-4216-9F4E-223273F1206FQ36254505-5DB08569-EDBD-4A27-B3B8-6D70EC682B4FQ36297476-DB2FB95A-107D-4F6C-8E11-5BC786D1E086Q36306199-7CF180CF-6163-4992-9089-BF01FA0E1ED8Q36478336-C02F69E2-3131-4EAE-83D5-1C96BE644C4EQ36593391-04496E0A-EB49-4262-B732-9E06F585B829
P2860
The changing and dynamic epidemiology of meningococcal disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The changing and dynamic epidemiology of meningococcal disease.
@en
The changing and dynamic epidemiology of meningococcal disease.
@nl
type
label
The changing and dynamic epidemiology of meningococcal disease.
@en
The changing and dynamic epidemiology of meningococcal disease.
@nl
prefLabel
The changing and dynamic epidemiology of meningococcal disease.
@en
The changing and dynamic epidemiology of meningococcal disease.
@nl
P2093
P50
P1433
P1476
The changing and dynamic epidemiology of meningococcal disease.
@en
P2093
Jane Jelfs
Lee H Harrison
Marco A P Sáfadi
Mary E Ramsay
Peter McIntyre
P304
P356
10.1016/J.VACCINE.2011.12.032
P407
P478
30 Suppl 2
P577
2011-12-15T00:00:00Z